Design, Synthesis and Molecular Docking Analysis of Flavonoid Derivatives as Potential Telomerase Inhibitors

Based on the structural scaffolds of natural products, two series of flavonoid derivatives, for a total of twelve compounds, were designed and synthesized as potential human telomerase inhibitors. Using a modified TRAP-PCR assay, compound <b>5c</b> exhibited the most potent inhibitory ac...

Full description

Bibliographic Details
Main Authors: Zhan-Fang Fan, Sai-Tim Ho, Rui Wen, Ya Fu, Lei Zhang, Jian Wang, Chun Hu, Pang-Chui Shaw, Yang Liu, Mao-Sheng Cheng
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/24/17/3180
id doaj-80fe24d922bf402fb352b6d091e38b55
record_format Article
spelling doaj-80fe24d922bf402fb352b6d091e38b552020-11-25T01:54:25ZengMDPI AGMolecules1420-30492019-09-012417318010.3390/molecules24173180molecules24173180Design, Synthesis and Molecular Docking Analysis of Flavonoid Derivatives as Potential Telomerase InhibitorsZhan-Fang Fan0Sai-Tim Ho1Rui Wen2Ya Fu3Lei Zhang4Jian Wang5Chun Hu6Pang-Chui Shaw7Yang Liu8Mao-Sheng Cheng9Key Laboratory of Structure-Based Drugs Design and Discovery (Ministry of Education), School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, ChinaSchool of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong, ChinaKey Laboratory of Structure-Based Drugs Design and Discovery (Ministry of Education), School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, ChinaKey Laboratory of Structure-Based Drugs Design and Discovery (Ministry of Education), School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, ChinaKey Laboratory of Structure-Based Drugs Design and Discovery (Ministry of Education), School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, ChinaKey Laboratory of Structure-Based Drugs Design and Discovery (Ministry of Education), School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, ChinaKey Laboratory of Structure-Based Drugs Design and Discovery (Ministry of Education), School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, ChinaSchool of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong, ChinaKey Laboratory of Structure-Based Drugs Design and Discovery (Ministry of Education), School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, ChinaKey Laboratory of Structure-Based Drugs Design and Discovery (Ministry of Education), School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, ChinaBased on the structural scaffolds of natural products, two series of flavonoid derivatives, for a total of twelve compounds, were designed and synthesized as potential human telomerase inhibitors. Using a modified TRAP-PCR assay, compound <b>5c</b> exhibited the most potent inhibitory activity against human telomerase with an IC<sub>50</sub> value of less than 50 &#956;M. In vitro, the results demonstrated that compound <b>5c</b> had potent anticancer activity against five classes of tumor cell lines. The molecular docking and molecular dynamics analyses binding to the human telomerase holoenzyme were performed to elucidate the binding mode of active compound <b>5c</b>. This finding helps the rational design of more potent telomerase inhibitors based on the structural scaffolds of natural products.https://www.mdpi.com/1420-3049/24/17/3180human telomerase holoenzymeflavonoidantiproliferative activitymolecular modeling
collection DOAJ
language English
format Article
sources DOAJ
author Zhan-Fang Fan
Sai-Tim Ho
Rui Wen
Ya Fu
Lei Zhang
Jian Wang
Chun Hu
Pang-Chui Shaw
Yang Liu
Mao-Sheng Cheng
spellingShingle Zhan-Fang Fan
Sai-Tim Ho
Rui Wen
Ya Fu
Lei Zhang
Jian Wang
Chun Hu
Pang-Chui Shaw
Yang Liu
Mao-Sheng Cheng
Design, Synthesis and Molecular Docking Analysis of Flavonoid Derivatives as Potential Telomerase Inhibitors
Molecules
human telomerase holoenzyme
flavonoid
antiproliferative activity
molecular modeling
author_facet Zhan-Fang Fan
Sai-Tim Ho
Rui Wen
Ya Fu
Lei Zhang
Jian Wang
Chun Hu
Pang-Chui Shaw
Yang Liu
Mao-Sheng Cheng
author_sort Zhan-Fang Fan
title Design, Synthesis and Molecular Docking Analysis of Flavonoid Derivatives as Potential Telomerase Inhibitors
title_short Design, Synthesis and Molecular Docking Analysis of Flavonoid Derivatives as Potential Telomerase Inhibitors
title_full Design, Synthesis and Molecular Docking Analysis of Flavonoid Derivatives as Potential Telomerase Inhibitors
title_fullStr Design, Synthesis and Molecular Docking Analysis of Flavonoid Derivatives as Potential Telomerase Inhibitors
title_full_unstemmed Design, Synthesis and Molecular Docking Analysis of Flavonoid Derivatives as Potential Telomerase Inhibitors
title_sort design, synthesis and molecular docking analysis of flavonoid derivatives as potential telomerase inhibitors
publisher MDPI AG
series Molecules
issn 1420-3049
publishDate 2019-09-01
description Based on the structural scaffolds of natural products, two series of flavonoid derivatives, for a total of twelve compounds, were designed and synthesized as potential human telomerase inhibitors. Using a modified TRAP-PCR assay, compound <b>5c</b> exhibited the most potent inhibitory activity against human telomerase with an IC<sub>50</sub> value of less than 50 &#956;M. In vitro, the results demonstrated that compound <b>5c</b> had potent anticancer activity against five classes of tumor cell lines. The molecular docking and molecular dynamics analyses binding to the human telomerase holoenzyme were performed to elucidate the binding mode of active compound <b>5c</b>. This finding helps the rational design of more potent telomerase inhibitors based on the structural scaffolds of natural products.
topic human telomerase holoenzyme
flavonoid
antiproliferative activity
molecular modeling
url https://www.mdpi.com/1420-3049/24/17/3180
work_keys_str_mv AT zhanfangfan designsynthesisandmoleculardockinganalysisofflavonoidderivativesaspotentialtelomeraseinhibitors
AT saitimho designsynthesisandmoleculardockinganalysisofflavonoidderivativesaspotentialtelomeraseinhibitors
AT ruiwen designsynthesisandmoleculardockinganalysisofflavonoidderivativesaspotentialtelomeraseinhibitors
AT yafu designsynthesisandmoleculardockinganalysisofflavonoidderivativesaspotentialtelomeraseinhibitors
AT leizhang designsynthesisandmoleculardockinganalysisofflavonoidderivativesaspotentialtelomeraseinhibitors
AT jianwang designsynthesisandmoleculardockinganalysisofflavonoidderivativesaspotentialtelomeraseinhibitors
AT chunhu designsynthesisandmoleculardockinganalysisofflavonoidderivativesaspotentialtelomeraseinhibitors
AT pangchuishaw designsynthesisandmoleculardockinganalysisofflavonoidderivativesaspotentialtelomeraseinhibitors
AT yangliu designsynthesisandmoleculardockinganalysisofflavonoidderivativesaspotentialtelomeraseinhibitors
AT maoshengcheng designsynthesisandmoleculardockinganalysisofflavonoidderivativesaspotentialtelomeraseinhibitors
_version_ 1724987619989782528